Medical Weight Loss for Lafayette, Louisiana Residents
Lafayette, Louisiana residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Lafayette through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Lafayette Residents Choose New Hope Weight Loss
Lafayette patients choose New Hope Weight Loss because a named physician, Dr. Anjmun Sharma, M.D., oversees every case, pricing is transparent (semaglutide from $166/month, tirzepatide from $233/month · just $7.70/day), and the entire program runs by telehealth from our Costa Mesa, California clinic, which has served over 5,400 patients across Louisiana and beyond since 2020.
Medical weight loss for Lafayette is handled end-to-end online: intake, the $119 physician review with Dr. Sharma, dose titration, and follow-ups, all by secure video, with no drive and no pharmacy line.
For Lafayette, medical weight loss is delivered online from our Costa Mesa, California practice, with no travel required. We care for patients throughout Downtown and the greater Acadiana region. Compounded semaglutide and tirzepatide ship directly to your door in Louisiana, and a licensed physician reviews every plan before anything is prescribed.
Telehealth removes the distance between Lafayette and specialized care: your consultation happens wherever you are in Louisiana. We accept HSA, FSA, Klarna, and Affirm, with no mandatory membership and no surprise charges for Lafayette patients.
GLP-1 Weight Loss Programs Available
Two GLP-1 programs for Lafayette
Compounded semaglutide starts at $166/month (a 90-day program is $499) and uses the same active ingredient as Wegovy® and Ozempic®, which produced 15-17% average body-weight loss in clinical trials. Compounded tirzepatide starts at $233/month and uses a dual GLP-1/GIP mechanism shown to reach up to 22.5% in trials.
Every plan begins with a $119 physician review. Medication is billed separately, and HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge.
How Telehealth Works for Lafayette
First, you complete the online medical intake in a few minutes. Next, Dr. Sharma reviews your history by secure video, usually within 48 hours. If you are a candidate and telehealth-eligible, your compounded medication ships to your Lafayette address in cold-pack packaging, and follow-ups and dose adjustments continue by video, with no travel.
Frequently Asked Questions, Lafayette
How do I get treatment from Lafayette?
As a Lafayette, Louisiana patient you connect with our Costa Mesa, California clinic by telehealth. Dr. Sharma oversees your plan by secure video and compounded medication ships to your home; eligibility is confirmed during the consultation.
Can I do this without an in-person visit from Lafayette?
Yes, it is fully telehealth. Your review, prescription, and follow-up are remote, with medication shipped to Lafayette in cold-pack packaging, no lines and no drive.
How much does it cost for Lafayette patients?
A $119 physician review, then compounded semaglutide from $166/month or tirzepatide from $233/month (medication separate). HSA, FSA, Klarna, and Affirm are accepted, and there is never a distance surcharge.
What areas of Lafayette do you serve?
We serve patients from across Lafayette by telehealth, including Downtown and the greater Acadiana region.
Is my health information private as a Lafayette patient?
Yes. Your intake, video visits, and records are handled under HIPAA safeguards, and medication arrives in discreet packaging. Lafayette patients get the same confidentiality as any telehealth patient.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Lafayette, Louisiana by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.